Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses
about
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@ast
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@en
type
label
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@ast
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@en
prefLabel
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@ast
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@en
P2860
P356
P1476
Could the FDA-approved anti-HI ...... nd molecular dynamics analyses
@en
P2093
Mahmoud E S Soliman
P2860
P304
P356
10.2147/DDDT.S87653
P407
P577
2015-11-13T00:00:00Z